The MSI2 gene was initially reported as a translocation partner with HOXA9 in patients progressing from chronic myelogenous leukemia to blast crisis (CML-BC)20. This evidence concerns the gene MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive.